Langer CJ - Search Results

1

Trastuzumab in the treatment of advanced non-small-cell lung cancer: is there a role? Focus on Eastern Cooperative Oncology Group study 2598.

Langer CJ, Stephenson P, Thor A, Vangel M, Johnson DH; Eastern Cooperative Oncology Group Study 2598. Langer CJ, et al. J Clin Oncol. 2004 Apr 1;22(7):1180-7. doi: 10.1200/JCO.2004.04.105. Epub 2004 Feb 23. J Clin Oncol. 2004. PMID: 14981103 Clinical Trial.

2

Phase II study of weekly 5-fluorouracil, cisplatin and vinblastine in advanced non-small cell lung cancer.

O'Dwyer PJ, Langer CJ, Walczak J, Levy MH, Padavic-Shaller K, Hudes GR, Litwin S, Comis RL. O'Dwyer PJ, et al. Among authors: langer cj. Eur J Cancer. 1991;27(12):1589-93. doi: 10.1016/0277-5379(91)90420-i. Eur J Cancer. 1991. PMID: 1664216

3

Etoposide and mitomycin in the treatment of non-small-cell lung cancer. A phase I-II evaluation.

Ettinger DS, Bitran JD, Comis RL, Langer CJ, Harwood KV, Harris CL, Keller JH, Losada M. Ettinger DS, et al. Among authors: langer cj. Am J Clin Oncol. 1991 Apr;14(2):127-32. doi: 10.1097/00000421-199104000-00007. Am J Clin Oncol. 1991. PMID: 1851388

4

Paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancer.

Langer CJ, Leighton J, McAleer C, Comis R, O'Dwyer P, Ozols R. Langer CJ, et al. Semin Oncol. 1995 Jun;22(3 Suppl 6):64-9. Semin Oncol. 1995. PMID: 7541156 Clinical Trial.

5

Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.

Langer CJ, Leighton JC, Comis RL, O'Dwyer PJ, McAleer CA, Bonjo CA, Engstrom PF, Litwin S, Ozols RF. Langer CJ, et al. J Clin Oncol. 1995 Aug;13(8):1860-70. doi: 10.1200/JCO.1995.13.8.1860. J Clin Oncol. 1995. PMID: 7543559 Clinical Trial.

6

Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience.

Langer CJ, Leighton JC, Comis RL, O'Dwyer PJ, McAleer CA, Bonjo CA, Engstrom PF, Litwin S, Johnson S, Ozols RF. Langer CJ, et al. Semin Oncol. 1995 Aug;22(4 Suppl 9):18-29. Semin Oncol. 1995. PMID: 7544025 Clinical Trial.

7

Optimal management of malignant mesothelioma after subtotal pleurectomy: revisiting the role of intrapleural chemotherapy and postoperative radiation.

Sauter ER, Langer C, Coia LR, Goldberg M, Keller SM. Sauter ER, et al. J Surg Oncol. 1995 Oct;60(2):100-5. doi: 10.1002/jso.2930600207. J Surg Oncol. 1995. PMID: 7564374 Clinical Trial.

8

Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx.

Fein DA, Lee WR, Hanlon AL, Ridge JA, Langer CJ, Curran WJ Jr, Coia LR. Fein DA, et al. Among authors: langer cj. J Clin Oncol. 1995 Aug;13(8):2077-83. doi: 10.1200/JCO.1995.13.8.2077. J Clin Oncol. 1995. PMID: 7636551 Clinical Trial.

9

Phase II evaluation of methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) in advanced, measurable breast carcinoma.

Langer CJ, Catalano R, Weiner LM, Scher R, Bagchi P, Saren B, Comis RL. Langer CJ, et al. Cancer Invest. 1995;13(2):150-9. doi: 10.3109/07357909509011684. Cancer Invest. 1995. PMID: 7874568 Clinical Trial.

10

Ifosfamide, carboplatin, and etoposide plus granulocyte-macrophage colony-stimulating factor: a phase I study with apparent activity in non-small-cell lung cancer.

Krigel RL, Palackdharry CS, Padavic K, Haas N, Kilpatrick D, Langer C, Comis R. Krigel RL, et al. J Clin Oncol. 1994 Jun;12(6):1251-8. doi: 10.1200/JCO.1994.12.6.1251. J Clin Oncol. 1994. PMID: 8201386 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

375 results

Search Page

Filters